Viewing nowRosuvastatin Calcium Tablets 5mg
Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication
Eden Pharma Co., Ltd.

MFDS item code 201803162 · Approved 2018.07.31 · Insurance code 628901100
Improvement of dyslipidemia; inhibition of atherosclerosis progression; prevention of cardiovascular diseases
This medication is used as an adjunct therapy when diet and exercise are insufficient to control primary hypercholesterolemia and mixed hyperlipidemia in patients. It is also used as an adjunct to diet and other treatments in patients with homozygous familial hypercholesterolemia to lower cholesterol levels. In patients with hypercholesterolemia, it effectively lowers total cholesterol and LDL cholesterol to desired levels, slowing the progression of atherosclerosis. Additionally, in pediatric patients aged 10 to 17 years who meet specific criteria, it is used as an adjunct to diet to lower cholesterol levels in cases of heterozygous familial hypercholesterolemia. It can also be used as adjunctive therapy in patients with primary dysbetalipoproteinemia. Finally, it helps reduce the risk of stroke, myocardial infarction, and arterial revascularization in men over 50 years and women over 60 years with certain cardiovascular risk factors. Overall, this medication is used to control cholesterol levels and improve cardiovascular health.
1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Before and during treatment with this medicine, patients should follow a standard cholesterol-lowering diet and continue it throughout the treatment period. This medicine may be taken at any time of day, with or without food. The initial dose is 5 mg once daily; the dose may be adjusted as a maintenance dose if a greater reduction in LDL cholesterol is needed. The maintenance dose is 10 mg once daily, and most patients are controlled at this dose. The maintenance dose should be adjusted appropriately at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and the patient's response; the dose may be increased to a maximum of 20 mg once daily. 3. Elderly patients: No dosage adjustment is necessary. 4. Patients with renal impairment: No dosage adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Particular caution is required when administering 20 mg of this medicine to patients with moderate renal impairment. 5. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this medicine to patients with active liver disease. 6. Race: Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 mg. Administration of the 40 mg dose is contraindicated. 7. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 mg. Administration of the 40 mg dose is contraindicated in some of these patients.
Pediatric patients with heterozygous familial hypercholesterolemia (aged 10 to 17 years): The usual dosage range is 5 milligrams to 20 milligrams once daily. (There are no clinical data on the administration of doses higher than 20 milligrams in pediatric patients.) The dose should be adjusted individually according to the recommended treatment goal for each patient. The dose should be adjusted at intervals of 4 weeks or more. Children under 10 years of age: Safety and efficacy have not been established.
This drug should not be used in certain patients. It is contraindicated in patients with an allergy to the ingredients of this drug, persistent unexplained liver dysfunction, muscle diseases, patients taking certain medications, patients with severe renal impairment, pregnant or breastfeeding women, and women of childbearing age not using appropriate contraception. Additionally, high-dose use of this drug is prohibited in patients at high risk for muscle diseases. Patients with genetic lactose intolerance should also avoid taking this drug. This medication should be used cautiously in patients with impaired liver function or those consuming alcohol excessively, and it is recommended to repeat liver function tests before and during treatment. Muscle pain, myopathy, and, rarely, a severe muscle degradation condition called rhabdomyolysis may occur; any symptoms related to muscles should be immediately reported to a healthcare provider. If there is a significant increase in muscle enzyme levels, the medication should be discontinued, and it may be restarted after the symptoms improve based on the doctor's judgment. In cases of acute renal failure or severity, the administration of this drug should be stopped, and if severe muscle weakness symptoms arise, it should be stopped immediately. Caution should be exercised as this medication may increase plasma concentrations when combined with certain drugs, leading to a higher risk of muscle disease; consult with healthcare providers regarding concomitant medications. This medication should not be taken during pregnancy or breastfeeding, and women who may become pregnant should use appropriate contraceptive methods. There is no specific antidote for overdose, so treatment based on symptoms and monitoring of liver function and muscle enzyme levels is necessary. This medication does not significantly affect driving or machine operation, but caution is advised as dizziness may occur. Lastly, if any unusual symptoms appear, such as liver dysfunction, muscle pain, or skin rashes while taking this medication, inform healthcare providers immediately.
Allergic reactions including angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, itching, rash, hives, myalgia, myopathy, rhabdomyolysis, weakness, polyneuropathy, amnesia, peripheral neuropathy, myasthenia gravis, cough, dyspnea, diarrhea, ocular myasthenia, thrombocytopenia, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms, drug-induced erythema multiforme, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, liver failure, cognitive decline, forgetfulness, amnesia, memory impairment, confusion, increased ALT, chest pain, muscle cramps, gout, erectile dysfunction, increased AST, numbness, sensory changes, chest discomfort, loss of appetite, abdominal distension, syncope, generalized pain, fatigue
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or moisture, so it must be stored in a tightly sealed container. It is best to maintain storage temperatures between 1 and 30 degrees Celsius at room temperature. Proper storage will help prolong the medication's effectiveness.
Yellow round film-coated tablets
28 tablets/Alu-Alu, 30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowRosuvastatin Calcium 5.2mg
Tablet · Prescription medication
Eden Pharma Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Dong Gu Bio Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Boryung Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Jongkundang Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.